tiprankstipranks
Trending News
More News >
Astria Therapeutics, Inc. (ATXS)
NASDAQ:ATXS
US Market

Astria Therapeutics (ATXS) Income Statement

Compare
1,167 Followers

Astria Therapeutics Income Statement

Last quarter (Q3 2025), Astria Therapeutics's total revenue was $706.00K, an increase of Infinity% from the same quarter last year. In Q3, Astria Therapeutics's net income was $-31.64M. See Astria Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 111.56M$ 83.03M$ 53.50M$ 194.98M$ 37.44M
Depreciation and Amortization
$ 0.00$ -15.20M$ 0.00$ 0.00$ 26.00K
EBITDA
$ -111.56M$ -83.03M$ -53.50M$ -30.36M$ -37.41M
Operating Income
$ -111.56M$ -83.03M$ -53.50M$ -194.98M$ -37.44M
Other Income/Expenses
$ 17.30M$ 10.14M$ 1.67M$ 64.00K$ 135.00K
Pretax Income
$ -94.26M$ -72.89M$ -51.83M$ -194.91M$ -37.30M
Net Income
$ -94.26M$ -72.89M$ -51.83M$ -194.91M$ -37.30M
Per Share Metrics
Basic EPS
$ -1.68$ -2.42$ -3.55$ -24.58$ -12.20
Diluted EPS
$ -1.68$ -2.42$ -3.55$ -24.58$ -12.20
Weighted Average Shares Outstanding
56.16M 30.12M 14.62M 8.93M 3.06M
Weighted Average Shares Outstanding (Diluted)
56.16M 30.12M 14.62M 8.93M 3.06M
Currency in USD

Astria Therapeutics Earnings and Revenue History